H2 receptor antagonists are commonly employed to manage gastro-esophageal reflux and peptic ulcer diseases with a very low incidence of side effects. Herein, we report an extremely rare incidence of famotidine-induced acute confusion in a patient with end-stage renal failure. We also discuss the pharmacokinetic properties of famotidine and its interplay with compromised renal function to result in neuropsychiatric manifestations, highlighting the importance of dosage adjustment in individuals with renal insufficiency.
OdehM., OlivenA.Central nervous system reactions associated with famotidine: report of five cases.J Clin Gastroenterol1998; 27: 253–4.
3.
YoshimotoK., SaimaS., EchizenH., NakamuraY., KondoT., YagishitaY.Famotidine-associated central nervous system reactions and plasma and cerebrospinal drug concentrations in neurosurgical patients with renal failure.Clin Pharmacol Ther1994; 55: 693–700.
4.
NaranjoC.A., BustoU., SellersE.M., SandorP., RuizI., RobertsE.A.A method for estimating the probability of adverse drug reactions.Clin Pharmacol Ther1981; 30: 239–45.
5.
EchizenH., IshizakiT.Clinical pharmacokinetics of famotidine.Clin Pharmacokinet1991; 21: 178–94.
6.
GladziwaU., KlotzU., KrishnaD.R., SchmittH., GlocknerW.M., MannH.Pharmacokinetics and dynamics of famotidine in patients with renal failure.Br J Clin Pharmacol1988; 26: 315–21.
